Assignee
SIGNALCHEM LIFESCIENCES CORP
CA·8 granted patents·1 pending application·5 citations·filing 2012–2022
Top patents by PatentIndex Score
9 records- 0179US9771333B2Quinazoline derivatives as TAM family kinase inhibitorsSIGNALCHEM LIFESCIENCES CORP·Filed 2014·Granted Sep 26, 2017·4 cites·26 claims
- 0274US10233176B2Aminopyridine derivatives as TAM family kinase inhibitorsSIGNALCHEM LIFESCIENCES CORP·Filed 2014·Granted Mar 19, 2019·1 cites·6 claims
- 0372US11034685B2Aminopyridine derivatives as TAM family kinase inhibitorsSIGNALCHEM LIFESCIENCES CORP·Filed 2020·Granted Jun 15, 2021·0 cites·4 claims
- 0471US11034686B2Aminopyridine derivatives as TAM family kinase inhibitorsSIGNALCHEM LIFESCIENCES CORP·Filed 2020·Granted Jun 15, 2021·0 cites·4 claims
- 0569US10723725B2Aminopyridine derivatives as TAM family kinase inhibitorsSIGNALCHEM LIFESCIENCES CORP·Filed 2019·Granted Jul 28, 2020·0 cites·5 claims
- 0657US2024100038A1Use of the axl inhibitor slc-391 as antiviral therapeutic agentSIGNALCHEM LIFESCIENCES CORP·Filed 2022·Application pending·0 cites
- 0746US10562859B2Aryl sulfonamide compounds as carbonic anhydrase inhibitors and their therapeutic useSIGNALCHEM LIFESCIENCES CORP·Filed 2016·Granted Feb 18, 2020·0 cites·17 claims
- 0845US12097194B2Combination therapy for treating blood cancerSIGNALCHEM LIFESCIENCES CORP·Filed 2019·Granted Sep 24, 2024·0 cites·12 claims
- 0937US10195174B2Carbonic anhydrase IX-related markers and use thereofSIGNALCHEM LIFESCIENCES CORP·Filed 2012·Granted Feb 5, 2019·0 cites·23 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →